Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.
about
Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data.Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation.Sirolimus pharmacokinetics in early postmyeloablative pediatric blood and marrow transplantation.Safety of voriconazole and sirolimus coadministration after allogeneic hematopoietic SCT.Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysisFactors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants.Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II.Minimizing the risk of recurrent or progressive invasive mold infections during stem cell transplantation or further intensive chemotherapy.Invasive fungal infections and antifungal therapies in solid organ transplant recipients.Antifungal agents--clinical pharmacokinetics and drug interactions.Concurrent administration of sirolimus and voriconazole: a pilot study assessing safety and approaches to appropriate management.Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia.Invasive mold infections: recent advances in management approaches.Safety of triazole antifungal drugs in patients with cancer.Management of drug and food interactions with azole antifungal agents in transplant recipients.Therapeutic drug monitoring in cancer chemotherapy.Update on the optimal use of voriconazole for invasive fungal infections.Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014.Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections.Voriconazole for prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplantation.Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4.Rifampin-sirolimus-voriconazole interaction in a hematopoietic cell transplant recipient.Successful use of posaconazole to treat invasive cutaneous fungal infection in a liver transplant patient on sirolimus.Drug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCT.Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation.
P2860
Q33559503-3504FE30-8A60-4689-93FE-3348EB1888FBQ34450423-649BDFAC-371A-4328-901A-4C0484B1B4C1Q34510280-0FC61211-5B9B-45CC-B069-7BE7DCD58B65Q35231368-27242A0E-3356-452D-9511-953AD445CE98Q35900978-0BB9B8C6-75A3-4B6D-AC72-336430DE1C32Q36662912-2B464E5B-CFCA-4E9A-B265-C76AED97CC79Q36777485-B9714C68-99DF-44C2-B9BC-5CE2AD21D7A6Q36867435-79F2EC8A-23BF-44D8-9902-E618D148758AQ36872848-9323E47C-39A9-4226-9798-0C39FC3EE2F9Q37159568-F7F91B88-F0CF-47FE-8FDD-A2CCAF0283A2Q37173189-BDFC7DC1-D433-42B4-8EC1-EFDD5FCA11C1Q37334707-EB20EFD0-EF67-4B13-8822-08CD7A494203Q37428946-72B9BEBE-0ABF-424E-8319-59A160FC10B7Q37662650-FE66015C-CB58-4C3C-ABF6-A76E535F0B91Q37775009-8261D8FB-DD92-4D81-8F1E-79BABB5E711CQ37810220-50003213-270B-497B-BF0D-392E4D6F9C77Q37892901-14F8CABC-D8FB-4B7A-ABA6-8C12A6B5B1B3Q38284468-B20BAECF-49B3-4FE7-A0AF-6B6AEBAFB630Q38880522-DA4394D3-4824-4431-BD32-B2191DCB55DFQ39196770-E68E767E-5E6E-4BFE-93DE-410036F09744Q39443748-1DEB972B-D082-44BE-9A20-8AF5FE519BCEQ40834681-E84141FC-1CB0-46E9-8CD2-EC8DC3F65BB8Q42184957-E5137EF9-F8E8-4368-AD78-2DF335FF8636Q43233993-5F1F41E3-CB3D-4779-A4C1-29AC827AE854Q50668499-3F0D6DE1-04EC-4CCB-8E48-FF7B25F2C4B3
P2860
Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Voriconazole and sirolimus coa ...... tic stem cell transplantation.
@ast
Voriconazole and sirolimus coa ...... tic stem cell transplantation.
@en
type
label
Voriconazole and sirolimus coa ...... tic stem cell transplantation.
@ast
Voriconazole and sirolimus coa ...... tic stem cell transplantation.
@en
prefLabel
Voriconazole and sirolimus coa ...... tic stem cell transplantation.
@ast
Voriconazole and sirolimus coa ...... tic stem cell transplantation.
@en
P2093
P1476
Voriconazole and sirolimus coa ...... tic stem cell transplantation.
@en
P2093
Bonnie J Campbell
Colleen M Lowry
Corey S Cutler
Francisco M Marty
Joseph H Antin
Karen Fiumara
P304
P356
10.1016/J.BBMT.2005.12.032
P577
2006-05-01T00:00:00Z